CVS Health Corporation (CVS): Price Target and June Short Interest Disclosure

CVS Health Corporation (CVS) : The consensus price target for CVS Health Corporation (CVS) is $111.68 for the short term with a standard deviation of $8.19. The most optimist securities analyst among the 22 who monitor the stock believes that the stock can reach $123, however, the pessimist price target for the company is $90.

The short interest in CVS Health Corporation (CVS) has declined from 13,846,220 on June 15,2016 to 12,315,629 on June 30,2016. The change was measured at 1,530,591 shares or 11.1%. The leftover shorts were 1.2% of the floated shares. The days to cover are 2, given the average daily volume of 6,396,883 shares. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 12th.

Also, Major Brokerage house, Morgan Stanley downgrades its ratings on CVS Health Corporation (NYSE:CVS). In the latest research report, Morgan Stanley lowers the target price from $111 per share to $104 per share. According to the latest information available, the shares are now rated Equal-weight by the analysts at the agency. The rating by the firm was issued on June 20, 2016.


CVS Health Corporation (NYSE:CVS): On Thursdays trading session , Opening price of the stock was $98.21 with an intraday high of $98.24. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $97.27. However, the stock managed to close at $97.46, a loss of 0.17% for the day. On the previous day, the stock had closed at $97.63. The total traded volume of the day was 4,816,118 shares.

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise, including over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, photo finishing, seasonal merchandise and greeting cards through the Companys retail stores, online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company, through its wholly owned subsidiary, Omnicare, Inc., provides pharmacy services to long term care facilities.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.